Labcorp Holdings Inc.
HealthcareNYSE:LH · New York Stock Exchange
-$1.19 today
Vol 0.37M · Avg 0.63M
Management
Put operating results in leadership context
Review returns on capital, executive background, insider transactions, and growth quality to judge whether management is compounding value well.
Return Metrics
ROE, ROIC & ROA over time
ROE
10.2%
avg 12.9%
ROIC
7.4%
avg 7.1%
ROA
4.8%
avg 5.7%
Analysis
ROE is currently the strongest return metric at 10.2% versus its period average of 12.9%. 0 of 3 return metrics are above their quality threshold, which helps indicate how efficiently the company turns capital and assets into profit.
Management
Key executives, compensation & ownership
| Name | Title | Compensation | Tenure | Age | Shares Owned | Ownership % |
|---|---|---|---|---|---|---|
Adam H. Schechter | President, Chief Executive Officer & Chairman | $4.18M | — | 61 | $107,234.00 | 0.13% |
Julia Wang | Chief Financial Officer & Executive Vice President | $1.68M | — | 54 | $4,964.00 | <0.01% |
Anita Z. Graham | Executive Vice President & Chief Human Resources Officer | $1.58M | — | 55 | $8,064.00 | <0.01% |
Brian J. Caveney | EVice President, President of Early Development Research Laboratories and Chief Medical & Scientific Officer | $1.49M | — | 52 | $39,410.92 | 0.05% |
Megan D. Bailey | Executive VP and President of Central Laboratory Services & International Labcorp | $1.15M | — | 46 | $5,332.00 | <0.01% |
Akinbolade Oyegunwa | Executive Vice President and Chief Information & Technology Officer | $876,616.00 | — | 43 | $5,446.25 | <0.01% |
Marcia T. Eisenberg | Enterprise Chief Scientific Officer & Senior Vice President | — | — | 67 | $41,550.00 | 0.05% |
Amy Summy | EVP, Chief Marketing Officer & Consumer Health Lead | — | — | 60 | $9,715.50 | 0.01% |
Kathryn Wright Kyle | Executive Vice President, Chief Legal Officer & Corporate Secretary | — | — | 55 | $3,813.46 | <0.01% |
Christin O'Donnell | Vice President of Investor Relations | — | — | — | — | — |
Bryan T. Vaughn | Executive Vice President of Diagnostics | — | — | 43 | $7,196.57 | <0.01% |
John Treadwell | Vice President of Transactions and Strategic Initiatives | — | — | — | $773.00 | <0.01% |
Jonathan C. Meltzer | EVP & Chief Operations Officer | — | — | — | $3,620.33 | <0.01% |
Peter J. Wilkinson | Senior Vice President & Chief Accounting Officer | — | — | 55 | $1,852.22 | <0.01% |
Insider Trading
SEC Form 4 transactions — last 12 months
Buys
0
$0.00
Sells
12
$7.15M
Net Sentiment
$7.15M
Net selling
Most Active
Meltzer Jonathan C
4 transactions
1–10 of 12
Analysis
Insiders reported 0 buys worth $0.00 and 12 sells worth $7.15M over the last 12 months. That adds up to net selling of $7.15M. Meltzer Jonathan C was the most active insider with 4 transactions.
Growth Analysis
Historical CAGR & forward analyst estimates
| Metric | 10yr | 5yr | 3yr | Fwd Est. |
|---|---|---|---|---|
| EPS | N/A | N/A | -10.2% | +12.2% (15yr)6 analysts |
| Revenue | N/A | N/A | +15.2% | +3.8% (15yr)6 analysts |
| Net Income | N/A | N/A | -9.2% | +10.9% (15yr)6 analysts |
| EBIT | N/A | N/A | -0.7% | +4.1% (15yr)6 analysts |
Analysis
Recent growth has been strongest in Revenue at +15.2% over three years. Forward estimates point to EPS at +12.2% (15yr), giving you a quick check on whether expectations are accelerating or cooling.
Competitors
Peer companies in the same sector
Biogen Inc.
NASDAQ:BIIB
$29.58B
DexCom, Inc.
NASDAQ:DXCM
$28.75B
Illumina, Inc.
NASDAQ:ILMN
$24.47B
West Pharmaceutical Services, Inc.
NYSE:WST
$23.28B
Waters Corporation
NYSE:WAT
$23.14B
United Therapeutics Corporation
NASDAQ:UTHR
$23.04B
Quest Diagnostics Incorporated
NYSE:DGX
$22.46B
Incyte Corporation
NASDAQ:INCY
$21.79B
STERIS plc
NYSE:STE
$20.29B
Zimmer Biomet Holdings, Inc.
NYSE:ZBH
$17.13B
Who manages LH?
Labcorp Holdings Inc. (LH) lists 14 active executives. The top listed executive is Brian J. Caveney, EVice President, President of Early Development Research Laboratories and Chief Medical & Scientific Officer.
Are LH insiders buying or selling?
Recent insider activity shows net selling of $3.70M.
Explore More
Continue the stock analysis
Jump to another research area for this company.